Involvement of sirtuins in life-span and aging related diseases

Advances in Experimental Medicine and Biology

Volumn 739, Issue , 2012, Pages 252-261

  Mahlknecht, Ulrich ^a   Zschoernig, Barbara ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMOYL PHOSPHATE SYNTHASE; CYTOCHROME C; GLUTAMATE DEHYDROGENASE; HISTONE DEACETYLASE; INSULIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; REACTIVE OXYGEN METABOLITE; RESVERATROL; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7;

AGING; ARTICLE; CALORIC RESTRICTION; CELL AGING; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; ENZYME ACTIVITY; HUMAN; INSULIN RELEASE; LIFESPAN; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; SIGNAL TRANSDUCTION; STRESS; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; DISEASES; LONGEVITY; METABOLISM; PATHOLOGY; REVIEW;

AGING; ANIMALS; DISEASE; HUMANS; LONGEVITY; SIRTUINS;

EID: 84859520675     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-1704-0_16     Document Type: Article

References (79)

1. Love R. Calorie restriction may be neuroprotective in AD and PD. Lancet Neurol 2005; 4:84.
2. Zschoernig B, Mahlknecht U. SIRTUIN 1: regulating the regulator. Biochem Biophys Res Commun 2008; 376:251-255.
3. Gruber J, Schaffer S, Halliwell B. The mitochondrial free radical theory of ageing-where do we stand? Front Biosci 2008; 13:6554-6579.
4. Oberdoerffer P, Sinclair DA. The role of nuclear architecture in genomic instability and ageing. Nat Rev Mol Cell Biol 2007; 8:692-702.
5. Kim SC, Sprung R, Chen Y et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell 2006; 23:607-618.
6. McCay CM, Crowell MF, Maynard LA. The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935. Nutrition 1989; 5:155-171; discussion 72.
7. Masoro EJ, Austad SN. The evolution of the anti-aging action of dietary restriction: a hypothesis. J Gerontol A Biol Sci Med Sci 1996; 51:B387-B391.
8. Masoro EJ. Caloric restriction and aging: an update. Exp Gerontol 2000; 35:299-305.
9. Weindruch R, Sohal RS. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med 1997; 337:986-994.
10. Weindruch R, Walford RL, Fligiel S et al. The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J Nutr 1986; 116:641-654.
11. Yu BP. How diet influences the aging process of the rat. Proc Soc Exp Biol Med 1994; 205:97-105.
12. Lane MA, Ball SS, Ingram DK et al. Diet restriction in rhesus monkeys lowers fasting and glucose-stimulated glucoregulatory end points. Am J Physiol 1995; 268:E941-E948.
13. Katic M, Kahn CR. The role ofinsulin and IGF-1 signaling in longevity. Cell Mol Life Sci 2005; 62:320-343.
14. Lane MA, Baer DJ, Rumpler WV et al. Calorie restriction lowers body temperature in rhesus monkeys, consistent with a postulated anti-aging mechanism in rodents. Proc Natl Acad Sci USA 1996; 93:4159-4164.
15. Roth GS, Ingram DK, Lane MA. Slowing ageing by caloric restriction. Nat Med 1995; 1:414-1415.
16. Kealy RD, Lawler DF, Ballam JM et al. Effects of diet restriction on life span and age-related changes in dogs. J Am Vet Med Assoc 2002; 220:1315-1320.
17. Pinney DO, Stephens DF, Pope LS. Lifetime effects of winter supplemental feed level and age at first parturition on range beef cows. J Anim Sci 1972; 34:1067-1074.
18. Mattison JA, Lane MA, Roth GS et al. Calorie restriction in rhesus monkeys. Exp Gerontol 2003; 38:35-46.
19. Roth GS, Mattison JA, Ottinger MA, et al. Aging in rhesus monkeys: relevance to human health interventions. Science 2004; 305:1423-1426.
20. Hadley EC, Lakatta EG, Morrison-Bogorad M et al. The future of aging therapies. Cell 2005; 120:557-567.
21. Heilbronn LK, Ravussin E. Calorie restriction and aging: review of the literature and implications for studies in humans. Am J Clin Nutr 2003; 78:361-369.
22. Roth GS. Caloric restriction and caloric restriction mimetics: current status and promise for the future. J Am Geriatr Soc 2005; 53:S280-S283.
23. Roth GS, Lane MA, Ingram DK. Caloric restriction mimetics: the next phase. Ann NY Acad Sci 2005; 1057:365-371.
24. Frye RA. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem Biophys Res Commun 1999; 260:273-279.
25. Frye RA. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 2000; 273:793-798.
26. Voelter-Mahlknecht S, Mahlknecht U. Cloning, chromosomal characterization and mapping of the NAD-dependent histone deacetylases gene sirtuin 1. Int J Mol Med 2006; 17:59-67.
27. Landry J, Sutton A, Tafrov ST et al. The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci USA 2000; 97:5807-5811.
28. Tanner KG, Landry J, Sternglanz R et al. Silent information regulator 2 family of NAD- dependent histone/ protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc Natl Acad Sci USA 2000; 97:14178-14182.
29. Michan S, Sinclair D. Sirtuins in mammals: insights into their biological function. Biochem J 2007; 404:1-13.
30. Longo VD, Kennedy BK. Sirtuins in aging and age-related disease. Cell 2006; 126:257-268.
31. Guarente L, Picard F. Calorie restriction-the SIR2 connection. Cell 2005; 120:473-482.
32. Saunders LR, Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 2007; 26:5489-5504.
33. Westphal CH, Dipp MA, Guarente L. A therapeutic role for sirtuins in diseases of aging? Trends Biochem Sci 2007; 32:555-560.
34. Mahlknecht U, Voelter-Mahlknecht S. Chromosomal characterization and localization ofthe NAD+-dependent histone deacetylase gene sirtuin 1 in the mouse. Int J Mol Med 2009; 23:245-252.
35. Sasaki T, Maier B, Bartke A et al. Progressive loss of SIRT1 with cell cycle withdrawal. Aging Cell 2006; 5:413-422.
36. Sommer M, Poliak N, Upadhyay S et al. DeltaNp63alpha overexpression induces downregulation of Sirt1 and an accelerated aging phenotype in the mouse. Cell Cycle 2006; 5:2005-2011.
37. Cohen HY, Miller C, Bitterman KJ et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science 2004; 305:390-392.
38. Chen D, Steele AD, Lindquist S et al. Increase in activity during calorie restriction requires Sirt1. Science 2005; 310:1641.
39. Bordone L, Cohen D, Robinson A et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell 2007; 6:759-767.
40. Rodgers JT, Lerin C, Haas W et al. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005; 434:113-118.
41. Lagouge M, Argmann C, Gerhart-Hines Z et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006; 127:1109-1122.
42. Lopez-Lluch G, Irusta PM, Navas P et al. Mitochondrial biogenesis and healthy aging. Exp Gerontol 2008; 43:813-819.
43. Araki T, Sasaki Y, Milbrandt J. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 2004; 305:1010-1013.
44. Brunet A, Sweeney LB, Sturgill JF et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303:2011-2015.
45. Kim D, Nguyen MD, Dobbin MM et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 2007; 26:3169-3179.
46. Howitz KT, Bitterman KJ, Cohen HY et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003; 425:191-196.
47. Wood JG, Rogina B, Lavu S et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004; 430:686-689.
48. Borra MT, Smith BC, Denu JM. Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 2005; 280:17187-17195.
49. Huang J, Gan Q, Han L et al. SIRT1 overexpression antagonizes cellular senescence with activated ERK/ S6kl signaling in human diploid fibroblasts. PLoS ONE 2008; 3:el710.
50. Baur JA, Pearson KJ, Price NL et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006; 444:337-342.
51. Milne JC, Lambert PD, Schenk S, et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007; 450:712-716.
52. Ota H, Akishita M, Eto M et al. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol 2007; 43:571-579.
53. Ota H, Tokunaga E, Chang K et al. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene 2006; 25:176-185.
54. Wang F, Nguyen M, Qin FX et al. SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 2007; 6:505-514.
55. North BJ, Marshall BL, Borra MT et al. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 2003; 11:437-444.
56. Jing E, Gesta S, Kahn CR. SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metab 2007; 6:105-114.
57. Voelter-Mahlknecht S, Ho AD, Mahlknecht U. FISH-mapping and genomic organization of the NAD-dependent histone deacetylase gene, Sirtuin 2 (Sirt2). Int J Oncol 2005; 27:1187-1196.
58. Lamming DW, Latorre-Esteves M, Medvedik O et al. HST2 mediates SIR2-independent life-span extension by calorie restriction. Science 2005; 309:1861-1864.
59. Outeiro TF, Kontopoulos E, Altmann SM et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science 2007; 317:516-519.
60. Michishita E, Park JY, Burneskis JM, et al. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell 2005; 16:4623-4635.
61. Schwer B, Bunkenborg J, Verdin RO et al. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc Natl Acad Sci USA 2006; 103:10224-10229.
62. Voelter-Mahlknecht S, Mahlknecht U. Cloning and structural characterization of the human histone deacetylase 6 gene. Int J Mol Med 2003; 12:87-93.
63. Shi T, Wang F, Stieren E et al. SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chem 2005; 280:13560-13567.
64. Hallows WC, Lee S, Denu JM. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc Natl Acad Sci USA 2006; 103:10230-10235.
65. Bellizzi D, Rose G, Cavalcante P, et al. A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 2005; 85:258-263.
66. Rose G, Dato S, Altomare K et al. Variability of the SIRT3 gene, human silent information regulator Sir2 homologue and survivorship in the elderly. Exp Gerontol 2003; 38:1065-1070.
67. Haigis MC, Mostoslavsky R, Haigis KM et al. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 2006; 126:941-954.
68. Mahlknecht U, Voelter-Mahlknecht S. Fluorescence in situ hybridization and chromosomal organization of the sirtuin 4 gene (Sirt4) in the mouse. Biochem Biophys Res Commun 2009; 382:685-690.
69. Aiuja N, Schwer B, Carobbio S et al. Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem 2007; 282:33583-33592.
70. Sdrnetz A, Min J, Antoshenko T et al. Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin. Structure 2007; 15:377-389.
71. Schlicker C, Gertz M, Papatheodorou P et al. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J Mol Biol 2008; 382:790-801.
72. Nakagawa T, Lomb DJ, Haigis MC et al. SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 2009; 137:560-570.
73. Liszt G, Ford E, Kurtev M et al. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem 2005; 280:21313-21320.
74. Mahlknecht U, Ho AD, Voelter-Mahlknecht S. Chromosomal organization and fluorescence in situ hybridization of the human Sirtuin 6 gene. Int J Oncol 2006; 28:447-456.
75. Mostoslavsky R, Chua KF, Lombard DB et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006; 124:315-329.
76. Lombard DB, Chua KF, Mostoslavsky R et al. DNA repair, genome stability and aging. Cell 2005; 120:497-512.
77. Ford E, Voit R, Liszt G et al. Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev 2006; 20:1075-1080.
78. Voelter-Mahlknecht S, Letzel S, Mahlknecht U. Fluorescence in situ hybridization and chromosomal organization of the human Sirtuin 7 gene. Int J Oncol 2006; 28:899-908.
79. Vakhrusheva O, Smolka C, Gajawada P et al. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ Res 2008; 102:703-710.